Pegvaliase – July 2026

Injection 2.5 mg in 0.5 mL pre-filled syringe
Injection 10 mg in 0.5 mL pre-filled syringe
Injection 20 mg in 1 mL pre-filled syringe  

  • Brand names:
    • Palynziq®
  • Pharmaceutical Company:
    • BIOMARIN PHARMACEUTICAL AUSTRALIA PTY LTD
  • Condition/Indication: Phenylketonuria (PKU)
  • Meeting Date: July 2026
Related Public Summary Documents

Last updated
12 November 2026